Adam Marks came to the Icahn School of Medicine at Mount Sinai from McGill University, where he majored in biochemistry. Prior to matriculating into the MD-PhD Program in 2018, Adam conducted post-baccalaureate research at Rockefeller University which looked to apply CRISPR-cas9 genome editing tools to human embryonic stem cells to study a variety of diseases with developmental etiologies.
Adam currently works in the lab of Dr. Brian Brown, where he is developing methods for controlling the cell- and organ-specific expression of gene therapies, such as RNA and DNA based drugs, with applications in cancer medicine, vaccinology, and genetic disease. While at Mount Sinai, Adam has also served as a Senior Clinician at the East Harlem Health Outreach Partnership (EHHOP) and works as a teaching assistant extensively between the graduate and medical schools. He is a co-founder of the Sinai Trivia League.
Adam thanks his parents, his dog (Casanova), his mentors, his friends, the MSTP leadership, and his colleagues.
Adam anticipates graduating with an MD-PhD degree in 2026.